Get notified when SUPN files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Asset Impairment (new) — Company recorded a $54.9M impairment charge on the APOKYN intangible asset in Q2 2026 as sales declined 51% YoY.
  • Sec Investigation (unchanged) — SEC Enforcement Division opened investigation into Sage's zuranolone NDA communications with FDA and material nonpublic information.
  • Securities Litigation (unchanged) — Federal securities class action filed against Sage Therapeutics alleging violations of Exchange Act Sections 10(b) and 20(a) for April 2021–July 2024 period.
NASDAQ: SUPN SUPERNUS PHARMACEUTICALS, INC. 10-Q

SUPN swings to $58M operating loss on $55M APOKYN impairment; announces Indivior merger

Filed August 3, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 5, 2025 · ~2 min read

Key Changes

  • high

    Operating income swung from $12.1M profit to $58.0M loss YoY, driven by a $54.9M APOKYN intangible asset impairment charge as sales declined 51% in Q2 2026.

    MD&A: APOKYN impairment verify on EDGAR →
  • high

    Announced merger-of-equals with Indivior on August 1, 2026. Supernus shareholders receive 1.5401 Indivior shares per share; Indivior shareholders receive $1.0B special dividend funded by $650M term loan and cash.

    MD&A: Indivior merger verify on EDGAR →
  • high

    Delaware Superior Court granted Partners full summary judgment June 5, 2026, on $27.7M milestone-payment dispute; principal, interest, fees, and costs remain to be determined.

    Legal Proceedings: Partners milestone verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (TRS 10-Q) is open in full — no account needed.

Partner

Trade SUPN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 4, 2026 · How we verify